Merkel cell carcinoma : Treatment and outcomes

The purpose of the current study was to determine the outcomes of patients with previously untreated Merkel cell carcinoma of the skin who were treated with curative intent. Between October 1984 and January 2002, 34 patients were treated with radiotherapy alone (2 patients) or combined with surgery...

Full description

Saved in:
Bibliographic Details
Published inCancer Vol. 104; no. 8; pp. 1761 - 1764
Main Authors MCAFEE, William J, MORRIS, Christopher G, MENDENHALL, Charles M, WERNING, John W, MENDENHALL, Nancy Price, MENDENHALL, William M
Format Journal Article
LanguageEnglish
Published New York, NY Wiley-Liss 15.10.2005
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The purpose of the current study was to determine the outcomes of patients with previously untreated Merkel cell carcinoma of the skin who were treated with curative intent. Between October 1984 and January 2002, 34 patients were treated with radiotherapy alone (2 patients) or combined with surgery (32 patients). Nine patients received adjuvant chemotherapy. Patients had follow-up for a median of 3.0 years (range, 0.3 to 18.5 yrs). Follow-up on living patients ranged from 2.2 to 18.5 years (median, 7.1 yrs). The 5-year outcomes were as follows: local control, 94%, locoregional control, 80%; freedom from distant metastases, 60%; cause-specific survival, 52%; and survival, 37%. No patient experienced a severe complication. Patients treated aggressively with surgery and locoregional radiotherapy have about a 50% chance of cure. Limited data suggest that definitive radiotherapy alone or after incomplete macroscopic resection may control locoregional disease in a significant subset of patients. The dominant site of failure was distant.
AbstractList The purpose of the current study was to determine the outcomes of patients with previously untreated Merkel cell carcinoma of the skin who were treated with curative intent. Between October 1984 and January 2002, 34 patients were treated with radiotherapy alone (2 patients) or combined with surgery (32 patients). Nine patients received adjuvant chemotherapy. Patients had follow-up for a median of 3.0 years (range, 0.3 to 18.5 yrs). Follow-up on living patients ranged from 2.2 to 18.5 years (median, 7.1 yrs). The 5-year outcomes were as follows: local control, 94%, locoregional control, 80%; freedom from distant metastases, 60%; cause-specific survival, 52%; and survival, 37%. No patient experienced a severe complication. Patients treated aggressively with surgery and locoregional radiotherapy have about a 50% chance of cure. Limited data suggest that definitive radiotherapy alone or after incomplete macroscopic resection may control locoregional disease in a significant subset of patients. The dominant site of failure was distant.
BACKGROUNDThe purpose of the current study was to determine the outcomes of patients with previously untreated Merkel cell carcinoma of the skin who were treated with curative intent.METHODSBetween October 1984 and January 2002, 34 patients were treated with radiotherapy alone (2 patients) or combined with surgery (32 patients). Nine patients received adjuvant chemotherapy. Patients had follow-up for a median of 3.0 years (range, 0.3 to 18.5 yrs). Follow-up on living patients ranged from 2.2 to 18.5 years (median, 7.1 yrs).RESULTSThe 5-year outcomes were as follows: local control, 94%, locoregional control, 80%; freedom from distant metastases, 60%; cause-specific survival, 52%; and survival, 37%. No patient experienced a severe complication.CONCLUSIONSPatients treated aggressively with surgery and locoregional radiotherapy have about a 50% chance of cure. Limited data suggest that definitive radiotherapy alone or after incomplete macroscopic resection may control locoregional disease in a significant subset of patients. The dominant site of failure was distant.
Abstract BACKGROUND The purpose of the current study was to determine the outcomes of patients with previously untreated Merkel cell carcinoma of the skin who were treated with curative intent. METHODS Between October 1984 and January 2002, 34 patients were treated with radiotherapy alone (2 patients) or combined with surgery (32 patients). Nine patients received adjuvant chemotherapy. Patients had follow‐up for a median of 3.0 years (range, 0.3 to 18.5 yrs). Follow‐up on living patients ranged from 2.2 to 18.5 years (median, 7.1 yrs). RESULTS The 5‐year outcomes were as follows: local control, 94%, locoregional control, 80%; freedom from distant metastases, 60%; cause‐specific survival, 52%; and survival, 37%. No patient experienced a severe complication. CONCLUSIONS Patients treated aggressively with surgery and locoregional radiotherapy have about a 50% chance of cure. Limited data suggest that definitive radiotherapy alone or after incomplete macroscopic resection may control locoregional disease in a significant subset of patients. The dominant site of failure was distant. Cancer 2005. © 2005 American Cancer Society. Patients treated aggressively with surgery and locoregional radiotherapy have about a 50% chance of cure. The dominant site of failure is distant.
Author MCAFEE, William J
MENDENHALL, Charles M
MORRIS, Christopher G
MENDENHALL, Nancy Price
MENDENHALL, William M
WERNING, John W
Author_xml – sequence: 1
  givenname: William J
  surname: MCAFEE
  fullname: MCAFEE, William J
  organization: Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, Florida, United States
– sequence: 2
  givenname: Christopher G
  surname: MORRIS
  fullname: MORRIS, Christopher G
  organization: Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, Florida, United States
– sequence: 3
  givenname: Charles M
  surname: MENDENHALL
  fullname: MENDENHALL, Charles M
  organization: Department of Radiation Oncology, Phoebe Putney Memorial Hospital, Albany, Georgia, United States
– sequence: 4
  givenname: John W
  surname: WERNING
  fullname: WERNING, John W
  organization: Department gf Otolaryngology, University of Florida College of Medicine, Gainesville, Florida, United States
– sequence: 5
  givenname: Nancy Price
  surname: MENDENHALL
  fullname: MENDENHALL, Nancy Price
  organization: Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, Florida, United States
– sequence: 6
  givenname: William M
  surname: MENDENHALL
  fullname: MENDENHALL, William M
  organization: Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, Florida, United States
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17160012$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/16136596$$D View this record in MEDLINE/PubMed
BookMark eNpFkMtKxEAQRRsZcR668QMkG10IidXvxJ0MvmDEzQjuQqcfEE06Y3ey8O_NOIHZVFFwuLc4SzTznbcIXWLIMAC5016HjGDK-QlaYChkCpiRGVoAQJ5yRj_naBnj13hKwukZmmOBqeCFWKDszYZv2yTaNuNQQde-a1Vyn2yDVX1rfZ8ob5Ju6HXX2niOTp1qor2Y9gp9PD1u1y_p5v35df2wSTWRrE8rrUEWYztnppKFyivCSC4oLyjVhSTGOWGAVE7Q3DjgVFfWYe6cpIZpwHSFbg65u9D9DDb2ZVvH_Y_K226IpciFxCJnI3h7AHXoYgzWlbtQtyr8lhjKvZ1yb6f8tzPCV1PqULXWHNFJxwhcT4CKWjUuKK_reOTGTgBM6B92IW06
CODEN CANCAR
Cites_doi 10.1002/cncr.21979
10.1200/JCO.2000.18.12.2493
10.1016/0360-3016(90)90484-2
10.1097/00005537-200405000-00023
10.1001/archotol.1984.00800370009002
10.1136/jcp.54.9.727
10.1097/00006534-200210000-00007
10.1001/archsurg.1991.01410360088014
10.1002/1097-0142(20010915)92:6<1650::AID-CNCR1491>3.0.CO;2-8
10.1007/s10434-001-0204-4
10.1016/0360-3016(92)90975-N
10.1001/archderm.1972.01620040075020
10.1200/JCO.2002.20.2.588
10.1016/0360-3016(94)E0145-A
ContentType Journal Article
Copyright 2005 INIST-CNRS
Copyright 2005 American Cancer Society
Copyright_xml – notice: 2005 INIST-CNRS
– notice: Copyright 2005 American Cancer Society
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1002/cncr.21355
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1097-0142
EndPage 1764
ExternalDocumentID 10_1002_cncr_21355
16136596
17160012
Genre Multicenter Study
Journal Article
GroupedDBID ---
-~X
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1CY
1L6
1OC
24P
29B
31~
33P
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5VS
66C
6J9
6P2
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
85S
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AAQOH
AARRQ
AAWTL
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABHFT
ABIJN
ABIVO
ABJNI
ABLJU
ABOCM
ABPPZ
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACMXC
ACNCT
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AGNAY
AHBTC
AI.
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C1A
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
E3Z
EBS
EJD
EMOBN
EX3
F00
F01
F04
F5P
FD6
FUBAC
G-S
G.N
GNP
GODZA
GX1
H.X
HBH
HF~
HGLYW
HHY
HHZ
HZ~
H~9
IH2
IQODW
IX1
J0M
J5H
JPC
KBYEO
KQQ
KZ1
L7B
LATKE
LAW
LC2
LC3
LH4
LITHE
LMP
LOXES
LP6
LP7
LSO
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N4W
N9A
NEJ
NF~
NNB
O66
O9-
OHT
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
Q.N
Q11
QB0
QRW
R.K
ROL
RSU
RWI
RX1
RYL
SJN
SUPJJ
TEORI
UDS
UHB
V2E
V8K
V9Y
VH1
W8V
W99
WBKPD
WH7
WHG
WHWMO
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WVDHM
WXI
WXSBR
XG1
XPP
XV2
Y6R
YQJ
Z0Y
ZGI
ZXP
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c274t-bcc07900854db79a8b2428635933c972dff6d02bf638df053cbef15ff73d4c013
ISSN 0008-543X
IngestDate Fri Aug 16 10:42:11 EDT 2024
Fri Aug 23 02:13:01 EDT 2024
Sat Sep 28 07:49:57 EDT 2024
Tue Sep 17 11:18:06 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Cancerology
Carcinoma
Prognosis
Treatment
treatment outcomes
Merkel cell carcinoma
Merkel cell
Malignant tumor
Radiotherapy
Language English
License CC BY 4.0
Copyright 2005 American Cancer Society
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c274t-bcc07900854db79a8b2428635933c972dff6d02bf638df053cbef15ff73d4c013
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 16136596
PQID 68671684
PQPubID 23479
PageCount 4
ParticipantIDs proquest_miscellaneous_68671684
crossref_primary_10_1002_cncr_21355
pubmed_primary_16136596
pascalfrancis_primary_17160012
PublicationCentury 2000
PublicationDate 2005-10-15
PublicationDateYYYYMMDD 2005-10-15
PublicationDate_xml – month: 10
  year: 2005
  text: 2005-10-15
  day: 15
PublicationDecade 2000
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
PublicationTitle Cancer
PublicationTitleAlternate Cancer
PublicationYear 2005
Publisher Wiley-Liss
Publisher_xml – name: Wiley-Liss
References e_1_2_5_13_2
e_1_2_5_16_2
e_1_2_5_8_2
American Joint Committee on Cancer (e_1_2_5_12_2) 2002
e_1_2_5_15_2
e_1_2_5_7_2
e_1_2_5_10_2
e_1_2_5_6_2
e_1_2_5_5_2
e_1_2_5_4_2
e_1_2_5_11_2
e_1_2_5_3_2
e_1_2_5_2_2
Leonard JH (e_1_2_5_9_2) 2000; 24
e_1_2_5_18_2
e_1_2_5_17_2
SAS Institute Inc. (e_1_2_5_14_2) 2003
References_xml – ident: e_1_2_5_15_2
  doi: 10.1002/cncr.21979
– ident: e_1_2_5_18_2
  doi: 10.1200/JCO.2000.18.12.2493
– volume-title: SAS OnlineDoc(r) version 9
  year: 2003
  ident: e_1_2_5_14_2
  contributor:
    fullname: SAS Institute Inc.
– ident: e_1_2_5_6_2
  doi: 10.1016/0360-3016(90)90484-2
– ident: e_1_2_5_17_2
  doi: 10.1097/00005537-200405000-00023
– ident: e_1_2_5_5_2
  doi: 10.1001/archotol.1984.00800370009002
– ident: e_1_2_5_10_2
  doi: 10.1136/jcp.54.9.727
– ident: e_1_2_5_4_2
  doi: 10.1097/00006534-200210000-00007
– volume: 24
  start-page: 620
  year: 2000
  ident: e_1_2_5_9_2
  article-title: Deletion mapping on the short arm of chromosome 1 in Merkel cell carcinoma
  publication-title: Cancer Detect Prev.
  contributor:
    fullname: Leonard JH
– ident: e_1_2_5_13_2
  doi: 10.1001/archsurg.1991.01410360088014
– volume-title: AJCC cancer staging manual
  year: 2002
  ident: e_1_2_5_12_2
  contributor:
    fullname: American Joint Committee on Cancer
– ident: e_1_2_5_11_2
  doi: 10.1002/1097-0142(20010915)92:6<1650::AID-CNCR1491>3.0.CO;2-8
– ident: e_1_2_5_7_2
  doi: 10.1007/s10434-001-0204-4
– ident: e_1_2_5_16_2
  doi: 10.1016/0360-3016(92)90975-N
– ident: e_1_2_5_2_2
  doi: 10.1001/archderm.1972.01620040075020
– ident: e_1_2_5_3_2
  doi: 10.1200/JCO.2002.20.2.588
– ident: e_1_2_5_8_2
  doi: 10.1016/0360-3016(94)E0145-A
SSID ssj0007253
Score 2.1796405
Snippet The purpose of the current study was to determine the outcomes of patients with previously untreated Merkel cell carcinoma of the skin who were treated with...
Abstract BACKGROUND The purpose of the current study was to determine the outcomes of patients with previously untreated Merkel cell carcinoma of the skin who...
BACKGROUNDThe purpose of the current study was to determine the outcomes of patients with previously untreated Merkel cell carcinoma of the skin who were...
SourceID proquest
crossref
pubmed
pascalfrancis
SourceType Aggregation Database
Index Database
StartPage 1761
SubjectTerms Adult
Aged
Aged, 80 and over
Antineoplastic Agents - therapeutic use
Biological and medical sciences
Carcinoma, Merkel Cell - drug therapy
Carcinoma, Merkel Cell - radiotherapy
Carcinoma, Merkel Cell - surgery
Carcinoma, Merkel Cell - therapy
Chemotherapy, Adjuvant
Combined Modality Therapy
Female
Humans
Male
Medical sciences
Middle Aged
Skin Neoplasms - drug therapy
Skin Neoplasms - radiotherapy
Skin Neoplasms - surgery
Skin Neoplasms - therapy
Survival Rate
Treatment Outcome
Tumors
Title Merkel cell carcinoma : Treatment and outcomes
URI https://www.ncbi.nlm.nih.gov/pubmed/16136596
https://search.proquest.com/docview/68671684
Volume 104
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdgSAgJofE1CmxEgjeU0jhubPNWbZkKaopUOrG3KHZsaQLSqU1f-Os5fzRepk18vERt1Cbt3eX8u_Pd7xB6xygEySPJ40zWLIYVmsdCKh0nRFY2HmDKpAaKeTY9I5_Px-dhvJXtLmnFUP66sa_kf7QK50Cvpkv2HzTbXRROwGvQLxxBw3D8Kx0Xav1d_Xhvku-GYlpeNKuflQ3yl7368dW2hdv7asFASyBDZW5xPDnNbWGkT8CE7aLiy2Lx6es1IoIwkqvI5yf5fDqZza7s3occ67d8Mfd9Ua5Ip5dmsPSkrtEyOLN4drHZ9Lwpi8fEzvMN3tRNE_Zmw674xoQ62nW_zsJbcqMPd5ywspHrIU5SR-LbJ8q-toB1ZYWG-sfgt7voHga_Y3ftF4FNjGJPSup_dsdWiz-Eu_XwycPLagOPinYzTm4PQiwYWe6jRz6KiCbOJB6jO6p5gu4Xvk7iKRo6y4iMZUSdZUQfo84uIrCLaGcXz9DZab48nsZ-MkYsMSUtPE5yRLmBy6QWlFdMANJigB15mkpOca11Vo-w0OBdaw1-Vgqlk7HWNK2JBNT_HO01q0a9QFHCxUinVCU1gHdK0wqzWgGoTAThKSCXAXq7k0d56QhQSkd1jUsjtdJKbYCOeqIKH_UqGaA3O9mV4MDM368atdpuyswwLGaMDNCBE2n4bmZqMHn28k8Xf4UeBJN9jfba9VYdAlZsxZG1gN-Tv2St
link.rule.ids 315,783,787,27936,27937
linkProvider Wiley-Blackwell
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Merkel+cell+carcinoma+%3A+Treatment+and+outcomes&rft.jtitle=Cancer&rft.au=MCAFEE%2C+William+J&rft.au=MORRIS%2C+Christopher+G&rft.au=MENDENHALL%2C+Charles+M&rft.au=WERNING%2C+John+W&rft.date=2005-10-15&rft.pub=Wiley-Liss&rft.issn=0008-543X&rft.volume=104&rft.issue=8&rft.spage=1761&rft.epage=1764&rft_id=info:doi/10.1002%2Fcncr.21355&rft.externalDBID=n%2Fa&rft.externalDocID=17160012
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-543X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-543X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-543X&client=summon